Author (Corporate) | European Commission: Press and Communication Service |
---|---|
Series Title | Press Release |
Series Details | IP/05/1065 (25.8.05) |
Publication Date | 25/08/2005 |
Content Type | News |
The European Commission on 25 August 2005 approved under the EU Merger Regulation the planned $24 billion (around €18 billion) acquisition by US healthcare group Johnson & Johnson (J&J) of its competitor Guidant, a US company specialised in cardiovascular medical products, subject to conditions. In particular the parties had to divest either J&J or Guidant Endoscopic Vessel Harvesting products ('EVH'), plus Guidant's EEA endovascular business and J&J's EEA Steerable Guidewires business. The Commission decision followed an in-depth investigation into the takeover. In light of the commitments given by J&J, the Commission has concluded that the transaction would not significantly impede effective competition in the European Economic Area (EEA) or a significant part of it. |
|
Source Link | http://europa.eu/rapid/pressReleasesAction.do?reference=IP/05/1065&format=HTML&aged=0&language=EN&guiLanguage=en |
Related Links |
|
Subject Categories | Internal Markets |
Countries / Regions | Europe |
![](https://www.europeansources.info/wp-content/uploads/esologo2.png)